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LETTER TO THE EDITOR
Immune Thrombocytopenic Purpura in a 5-Month-Old Female
With Rotavirus Infection
To the Editor: Immune thrombocytopenic purpura (ITP) in
infants may occur following immunizations and usually has good
response to treatment with no recurrence after booster immuniza-
tion with same vaccines. ITP has not been reported to be associated
with either rotavirus infection or vaccine. We would like to report
the case of an infant who presented with severe gastrointestinal
bleeding secondary to ITP, which developed following acute
rotavirus infection after having received two doses of the oral
pentavalent rotavirus vaccine.
A 5-month-old previously healthy, African American female
presented to the emergency room, with low-grade fever, hema-
tochezia, and non-bloody emesis that lasted for about 48 hr. She had
received her second set of immunizations, including oral pentava-
lent rotavirus vaccine, 1 week prior to presentation. Physical exam
revealed multiple petichiae over her entire body but no viscer-
omegaly. Barium enema was negative for intussusception, although
stool enzyme immunoassay was positive for rotavirus. Platelet
count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and
white blood cell count was 8,300/cmm with normal differentials. On
peripheral blood smear she had normochromic, normocytic red
blood cells with polychromasia and occasional schistocytes, giant
platelets, and no blasts. Direct Coomb’s test was negative, blood
urea nitrogen, serum creatinine, coagulation studies, compliment
factors, liver functions, and immunoglobulin levels were all within
normal limits, lactate dehydrogenase was 399 U/L; serologies for
human immunodeficiency virus, Epstein–Barr virus, cytomegalo-
virus, and Parvovirus-B19 were negative. Her bone marrow showed
normal cellularity with increased number of megakaryocytes. She
was stabilized with packed red blood cell transfusion and intra-
venous fluids, but the platelet count dropped down to 3,000/cmm.
Thrombotic thrombocytopenic purpura was ruled out with normal
ADAMTS-13 levels, though fresh frozen plasma was given prior to
this. Patient was given 1 g/kg body weight, infusion of intravenous
immunoglobulin (IVIG) in two divided doses and platelet counts
rose up to 32,000/cmm within the next 2 days. She was discharged
home with recommendations for close follow-up. She required three
more doses of IVIG for recurrent drop in platelet counts, over the
next 2 months, with a good response each time; while no bleeding
was reported. Following the fourth dose of IVIG, her platelet
count increased to 192,000/cmm and subsequently remained over
150,000/cmm without intervention. After 4 months of follow-up,
she continues to do well and her hemoglobin has remained stable.
She was advised not to receive the third dose of rotavirus vaccine.
The development of serious rotavirus gastroenteritis in a
partially vaccinated infant is rare but is known to occur. We propose
that the development of ITP in this infant might have been
associated with rotavirus infection, although this could have been an
incidental finding. The prevalence of rotavirus infection is very high
worldwide and it would be of interest to perform an analysis
examining platelet counts and hemoglobin in infants diagnosed with
acute rotavirus infections.
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